Lisdexamfetamine dimesylate 50 mg/1 (Lisdexamfetamine dimesylate CAPSULE) 50 mg/1

Lisdexamfetamine dimesylate is a prodrug that is converted in the body to dextroamphetamine. It works by increasing the levels of norepinephrine and dopamine in the central nervous system, which helps to improve attention and control behaviors associated with ADHD and BED.

The recommended starting dosage in adults and pediatric patients 6 years and older is 30 mg once daily in the morning. Dosage may be adjusted in increments of 10 mg or 20 mg at approximately weekly intervals up to a maximum recommended dosage of 70 mg once daily. The prescriber sets the exact dosage based on individual patient response and medical condition.

Lisdexamfetamine dimesylate is classified as a pregnancy category C drug, meaning it should be used during pregnancy only if the potential benefits outweigh the risks. It is not recommended for use during breastfeeding as it may pass into breast milk and affect the nursing infant. Always consult a healthcare provider for personalized advice.

To order Lisdexamfetamine dimesylate from GNH India, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams across international markets. The team will ask you to confirm your trade or institutional credentials and will reply with pricing, availability, shipping, and the necessary import paperwork.

Lisdexamfetamine dimesylate is a prodrug that is converted to dextroamphetamine in the body, providing a smoother onset and more gradual effect compared to immediate-release amphetamines. It is less likely to be misused by snorting or injecting due to its formulation. The choice of ADHD medication depends on individual patient response and medical history.

Lisdexamfetamine dimesylate should be stored at room temperature, 20°C to 25°C (68°F to 77°F). Excursions permitted between 15°C and 30°C (59°F to 86°F). Keep the medication in its original packaging, protect from moisture and light, and ensure it is kept out of reach of children and pets.

Lisdexamfetamine dimesylate is taken orally once daily in the morning. The capsules should be swallowed whole with water. If a patient has difficulty swallowing the capsule, it can be opened and the contents mixed with yogurt or water and taken immediately. Chewable tablets should be chewed thoroughly before swallowing.

The most serious risks associated with Lisdexamfetamine dimesylate include increased heart rate or blood pressure, psychiatric symptoms such as hallucinations or agitation, circulation problems in fingers and toes, serious heart problems, seizures, and the risk of abuse and dependence. Patients should be monitored closely for these potential side effects.

Lisdexamfetamine dimesylate should not be used by individuals with serious heart problems, a history of heart disease, severe agitation, or those who have taken a monoamine oxidase inhibitor (MAOI) in the past 14 days. It should also be used with caution in patients with a history of substance abuse or mental health conditions.